Evidence map›Paper›PMID 40640238›Full record

Trial reportScientific reports2025

Post-hoc mediation analysis of two biomarkers, and survival in acute respiratory distress syndrome.

Laurent Renard Triché, Matthieu Jabaudon, Sylvie Chevret, Jean-Michel Constantin, Bruno Pereira, Nicolas Molinari

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Laurent Renard TrichéDepartment of Perioperative Medicine, CHU Clermont-Ferrand, 58 Rue Montalembert, 63 003, Clermont-Ferrand, France. lrenardtriche@chu-clermontferrand.fr.ORCID http://orcid.org/0000-0002-3971-9093
Matthieu JabaudonDepartment of Perioperative Medicine, CHU Clermont-Ferrand, 58 Rue Montalembert, 63 003, Clermont-Ferrand, France.ORCID http://orcid.org/0000-0002-8121-1680
Sylvie ChevretECSTRRA Team, IRSL, INSERM UMR1342, Université Paris Cité, Paris, France.ORCID http://orcid.org/0000-0001-6449-4730
Jean-Michel ConstantinGRC 29, DMU DREAM, Department of Anesthesiology and Critical Care, Pitié-Salpêtrière Hospital, AP-HP, Sorbonne University, Paris, France.ORCID http://orcid.org/0000-0001-7634-5898
Bruno PereiraBiostatistics Unit, Department of Clinical Research, and Innovation (DRCI), CHU Clermont-Ferrand, Clermont-Ferrand, France.ORCID http://orcid.org/0000-0003-3778-7161
Nicolas MolinariDesbrest Institute of Epidemiology and Public Health (IDESP), INSERM UMR UA11, INRIA PreMEdical, University of Montpellier, Montpellier, France.ORCID http://orcid.org/0000-0002-1786-0088

Funding

Agence Nationale de la Recherche RESPIRE ProjectFonds Européen de Développement Régional ASTRA Project
6 · The paper itself

Abstract

Previous studies have shown that plasma soluble receptor for advanced glycation end-products (sRAGE) and the radiographic assessment of lung edema (RALE) are associated with the severity of acute respiratory distress syndrome (ARDS) both at baseline and over time. This study aims to explore the causal relationships among sRAGE, the RALE score, their fluctuations, and 90-day survival. Causal mediation analysis was conducted as a secondary analysis of the randomized controlled lung imaging for ventilator setting in ARDS (LIVE) trial, which assessed a mechanical ventilation strategy based on lung morphology. The primary outcome was survival at day 90. We used group-based trajectory modeling to summarize the biomarker patterns over time, followed by mediation analysis with the sRAGE and RALE score as mediators. Out of 400 patients in the LIVE study, 115 were included, resulting in three trajectory groups for both sRAGE and RALE. The mechanical ventilation strategy appeared to influence survival directly and indirectly: one indirect effect was mediated by one RALE score trajectory (aligning with the direct effect), and another by one sRAGE trajectory (opposing the direct effect). Both plasma sRAGE and the RALE score appeared to exhibit a mediation effect on survival for specific patient clusters. Identifying these clusters and using biomarkers as surrogate endpoints warrants further investigation in precision ARDS trials.

Indexed as

BiomarkersReceptor for Advanced Glycation End ProductsRespiratory Distress SyndromeAgedFemaleHumansLungMaleMediation AnalysisMiddle AgedPulmonary EdemaRespiration, ArtificialBiomarkersReceptor for Advanced Glycation End ProductsArtificialCausalityCluster analysisCritical carePrecision medicineRespiration

Identifiers

PMID40640238
PMCPMC12246399

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.